adr_usa_0488|MREO|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
adr_usa_0488|MREO|1|Mereo BioPharma Group PLC Total Current Assets (Quarterly) (USD)|Mereo BioPharma Group PLC Cash and Short Term Investments (Quarterly) (USD)|Mereo BioPharma Group PLC Inventories (Quarterly) (USD)|Mereo BioPharma Group PLC Net PP&E (Quarterly) (USD)|Mereo BioPharma Group PLC Goodwill and Intangibles (Quarterly) (USD)|Mereo BioPharma Group PLC Total Liabilities (Quarterly) (USD)|Mereo BioPharma Group PLC Total Current Liabilities (Quarterly) (USD)|Mereo BioPharma Group PLC Total Long Term Liabilities (Quarterly) (USD)|Mereo BioPharma Group PLC Total Deposits (Quarterly) (USD)|Mereo BioPharma Group PLC Book Value (Quarterly) (USD)|Mereo BioPharma Group PLC Retained Earnings (Quarterly) (USD)|Mereo BioPharma Group PLC Treasury Stock (Quarterly) (USD)|Mereo BioPharma Group PLC EV to Revenues|Mereo BioPharma Group PLC EV to Earnings|Mereo BioPharma Group PLC EV to Free Cash Flow|Mereo BioPharma Group PLC EV to Assets (Quarterly)|Mereo BioPharma Group PLC PS Ratio|Mereo BioPharma Group PLC PE Ratio|Mereo BioPharma Group PLC Price to Book Value|Mereo BioPharma Group PLC PEG Ratio|Mereo BioPharma Group PLC Debt to Equity Ratio|Mereo BioPharma Group PLC Dividend Yield|Mereo BioPharma Group PLC Shareholder Yield (TTM)|Mereo BioPharma Group PLC Percent of Shares Outstanding Short|Mereo BioPharma Group PLC Total Receivables (Quarterly) (USD)|Mereo BioPharma Group PLC Total Payables (Quarterly) (USD)|Mereo BioPharma Group PLC Total Capital Stock (Quarterly) (USD)|Mereo BioPharma Group PLC Return on Invested Capital|Mereo BioPharma Group PLC Quality Ratio Score|Mereo BioPharma Group PLC Momentum Score|Mereo BioPharma Group PLC Beta (1Y)|Mereo BioPharma Group PLC Sustainable Growth Rate (TTM)|Mereo BioPharma Group PLC Institutional Investor Ownership Percentage|Mereo BioPharma Group PLC Average Diluted Shares Outstanding (Quarterly)|Mereo BioPharma Group PLC Total Employees (Annual)|Mereo BioPharma Group PLC EPS Diluted (Quarterly) (USD)|Mereo BioPharma Group PLC Shares Outstanding|Mereo BioPharma Group PLC Repurchase of Capital Stock (Quarterly) (USD)|Mereo BioPharma Group PLC Ordinary Shares Number (Quarterly)|Mereo BioPharma Group PLC Payout Ratio|Mereo BioPharma Group PLC Quick Ratio (Quarterly)|Mereo BioPharma Group PLC Normalized Diluted EPS (Quarterly) (USD)|Mereo BioPharma Group PLC Stock Buybacks (Quarterly) (USD)|Mereo BioPharma Group PLC Effective Tax Rate (TTM)|Mereo BioPharma Group PLC Return on Equity|Mereo BioPharma Group PLC Net Income (TTM) (USD)|Mereo BioPharma Group PLC Revenue (TTM) (USD)|Mereo BioPharma Group PLC Dividend Per Share (Quarterly) (USD)|Mereo BioPharma Group PLC Revenue (Quarterly) (USD)|Mereo BioPharma Group PLC Gross Profit (Quarterly) (USD)|Mereo BioPharma Group PLC SG&A Expense (Quarterly) (USD)|Mereo BioPharma Group PLC Pre-Tax Income (Quarterly) (USD)|Mereo BioPharma Group PLC Net Income (Quarterly) (USD)|Mereo BioPharma Group PLC Net Interest Income (Quarterly) (USD)|Mereo BioPharma Group PLC Price (USD)|Mereo BioPharma Group PLC Total Return Price (USD)|Mereo BioPharma Group PLC Enterprise Value (USD)|Mereo BioPharma Group PLC 30-Day Average Daily Volume|Mereo BioPharma Group PLC 1 Year Price Returns (Daily)||
adr_usa_0488|MREO|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
adr_usa_0488|MREO|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
adr_usa_0488|MREO|5|182.555555556|182.555555556|0|182.555555556|182.555555556|182.555555556|182.555555556|182.555555556|0|182.555555556|182.555555556|182.4|0|0|1.44210526316|0|0|0|1.44210526316|0|0|1.44210526316|0|15.2647058824|182.555555556|182.555555556|182.555555556|0|0|30.5|30.6|0|30.4545454545|0|365.25|0|71.4782608696|0|182.555555556|0|0|0|0|182.625|0|182.625|0|0|0|0|0|0|0|0|1.44210526316|1.44210526316|1.44210526316|1.4415954416|1.43307086614||
adr_usa_0488|MREO|6|9|9|0|9|9|9|9|9|0|9|9|5|0|0|380|0|0|0|380|0|0|380|0|34|9|9|9|0|0|4|5|0|11|0|4|0|23|0|9|0|0|0|0|8|0|8|0|0|0|0|0|0|0|0|380|380|380|351|127||
adr_usa_0488|MREO|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
adr_usa_0488|MREO|201512|20.5108|18.1454||0.303|38.2419|6.102|5.8927|0.2094||52.9536|-18.0579||||||||||||||1.5546|2.0578|0.0877||||||||14||12.8682||64.3408||||||||||||||||||||||
adr_usa_0488|MREO|201606|100.6374|94.471||0.2547|34.7486|13.293|7.8277|5.4652||122.3477|-26.8095||||||||||||||5.1576|7.8277|0.2598||||||||||12.8682||64.3408|||||12.8473||-21.1536|||||||||||||||
adr_usa_0488|MREO|201612|74.6664|65.8206||0.2136|31.7115|9.2237|3.9424|5.2813||97.3677|-49.852||||||||||||||7.127|1.3773|0.2371||||||||20||12.8682||64.3408|||||15.5944||-38.1263|||||||||||||||
adr_usa_0488|MREO|201703|||||||||||||||||||||||||||||||||||||14.1208||||||||||||||||||||||||
adr_usa_0488|MREO|201706|82.933|73.6058||0.2189|33.5832|20.4126|15.5211|4.8915||96.3224|-73.1943||||||||||||||6.5451|15.5211|0.2756||||||||||14.1208||70.6042|||||17.4548||-46.0449|||||||||||||||
adr_usa_0488|MREO|201709|||||||||||||||||||||||||||||||||||||14.219||||||||||||||||||||||||
adr_usa_0488|MREO|201712|85.3772|71.0089||0.2073|44.6033|45.7476|12.9972|32.7503||84.4402|-107.1875|0|||||||||||||11.3038|4.0867|0.2882||||||||31||14.219||71.095|||||17.3784||-50.3941|||||||||||||||
adr_usa_0488|MREO|201806|64.3758|48.2589||0.1987|42.7389|45.6707|18.4917|27.179||61.6426|-125.7442||||||||||||||14.5144|6.5155|0.279||||||||||14.229||71.145|||||15.2653||-44.4712|||||||||||||||
adr_usa_0488|MREO|201809|||||||||||||||||||||||||||||||||||||14.2481||||||||||||||||||||||||
adr_usa_0488|MREO|201812|43.7707|34.948||0.1891|41.4067|43.7834|20.527|23.2564||41.5831|-141.1283|0.3896|||||||||||||7.097|5.7989|0.2715||||||||31||14.2481||71.2403|||||14.0878||-42.5007|||||||||||||||
adr_usa_0488|MREO|201903|||||||||||||||-3.2252||||2.5863|||0||0.0347|||||||||||||19.2047||||||||||||||||||5.6|5.6|99.8606|||4.25|
adr_usa_0488|MREO|201906|61.9502|45.7711||16.6017|57.2262|60.9687|26.6936|34.2751||74.8094|-161.3962|1.6536|||-1.3463||||1.1873|||0||0.0195|12.2907|8.5646|0.3724||||||10.3217||||19.5919||97.9596|||||14.6617||-40.2023|||||||||2.52|2.52|41.6859|15523.6||2.6|3.67
adr_usa_0488|MREO|201909|||||||||||||||-0.8188||||0.7804|||0||0.0132|||||||||10.1649||||||||||||||||||||||2.98|2.98|37.6191|9906.1333||2.9355|2.37
adr_usa_0488|MREO|201912|39.9055|21.4337||15.1545|58.2894|60.5669|39.1751|21.3917||52.7825|-191.516|1.7111|||-1.18||||1.2175|||0||1.5811|15.3197|8.3286|0.3855||||||7.9176||50||19.5919||97.9596|||||15.2608||-44.838|||||||||3.28|3.28|69.7225|354326.6667||1.682|1.85
adr_usa_0488|MREO|202003|||||||||||||||-0.5328||||0.493|||0||0.1377||||||1|1.3559||19.6682||||||||||||||||||||||1.045|1.045|31.4832|94016.1333|-75.5357|1.37|1.27
adr_usa_0488|MREO|202006|82.077|69.9404||13.8167|39.2358|105.2903|27.5325|77.7578||29.8392|-333.1785|1.6063|||-4.585||||6.947|||0||0.6413|10.4133|6.7564|1.2506|||1|2.1624||87.4354||||67.7428||338.714|||||3.6444||-178.5281|||||||||3.06|3.06|171.5221|537082.1|21.4286|2.85|2.99
adr_usa_0488|MREO|202009|||||||||||||||-3.7882||||5.9481|||0||1.3969||||||4|2.0825||||||||||||||||||||||||2.62|2.62|141.7152|232347.5667|-12.0805|2.59|
adr_usa_0488|MREO|202406|||||||||||||||||||7.9375||||||||||||||||||153.8525||||||||||||||||||4.06|4.06|541.7831|1003645.6333||4.69|
adr_usa_0488|MREO|202409||80.522||||16.21|||||||||||||8.7675|||||||||||||||||-0.1|154.7345|||||||||-45.316|||||6.203||-15.001||4.11|4.11|560.9878|850208.2||4.21|3.605
adr_usa_0488|MREO|202412||69.802||||15.421|||||||||||||8.9063|||||||||||||||||-0.05|155.1456|||||||||-43.253|||||6.454||-7.046||3.5|3.5|478.7426|943107.9667||3.01|2.4
adr_usa_0488|MREO|202503||62.483||||8.241|||||||||||||5.9545|||||||||||||||||-0.1|159.0003|||||||||-47.189|||||7.272||-12.887||2.25|2.25|295.2677|1417562.7667||2.59|2.15
adr_usa_0488|MREO|202506|||||||||||||||||||7.1718||||||||||||||||||||||||||||||||||||2.71|2.71|368.4078|1192137.3667||2.87|